论文部分内容阅读
炎性乳腺癌(IBC)是一种少见的、预后差的乳腺肿瘤,占乳腺癌发病总数的2%~5%。临床症状与急性乳腺炎类似,起病快,病程发展迅速,累及范围广,可累及整个胸壁,类似铠甲,又称“铠甲样”癌。临床上不容易被及时明确诊断,有些患者容易误诊为急性乳腺炎。因此,尽早明确诊断对炎性乳腺癌的患者至关重要,诊断后联合应用新辅助化疗、靶向治疗等多种治疗方法可改善患者的预后。
Inflammatory breast cancer (IBC) is a rare, poor-prognosis breast cancer that accounts for 2% to 5% of the total breast cancer. Clinical symptoms are similar to those of acute mastitis, with rapid onset, rapid disease progression, and a wide range of involvement, which can affect the entire chest wall. Similar to armor, it is also known as a “squamous armor-like” cancer. Clinically it is not easy to be diagnosed in a timely manner, and some patients are easily misdiagnosed as acute mastitis. Therefore, it is essential to diagnose patients with inflammatory breast cancer as early as possible. After diagnosis, multiple treatment methods such as neoadjuvant chemotherapy and targeted therapy can improve the prognosis of patients.